You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Cadila Healthcare Ltd"

Cadila Healthcare Ltd Zydus Announces Settlement of a DELZICOL? (mesalamine) Patent Litigation

  • 03/12/2016
  • |
  • bse

Cadila Healthcare Ltd Cadila Healthcare Ltd reply to clarification sought by the exchange

  • 23/11/2016
  • |
  • bse

Cadila Healthcare Ltd Clarification sought from Cadila Healthcare Ltd

  • 23/11/2016
  • |
  • bse

Cadila Healthcare Ltd Zydus receives final approval from the USFDA for Metroniazole Tables

  • 21/11/2016
  • |
  • bse

Cadila Healthcare Ltd Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

  • 18/11/2016
  • |
  • bse

Cadila Healthcare Ltd Outcome of Board Meeting - Scheme of Arrangement

  • 17/11/2016
  • |
  • bse

Cadila Healthcare Ltd Presentation

  • 15/11/2016
  • |
  • bse

Cadila Healthcare Ltd Zydus To Present New Scientific Data of Investigational Saroglitazar at the 2016 AASLD Liver Meeting

  • 31/10/2016
  • |
  • bse

Cadila Healthcare Ltd Announces Q2 Results (Standalone & Consolidated) & Limited Review Report (Standalone & Consolidated)

  • 26/10/2016
  • |
  • bse

Cadila Healthcare Ltd Post results conference call with investors/ analysts

  • 19/10/2016
  • |
  • bse

Cadila Healthcare Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended S

  • 12/10/2016
  • |
  • bse

Cadila Healthcare Ltd Q2 results on Oct 26 2016

  • 07/10/2016
  • |
  • bse

Cadila Healthcare Ltd Zydus signs in-licensing deal with Neovii of Switzerland

  • 06/10/2016
  • |
  • bse

Cadila Healthcare Ltd Zydus and Medicines for Malaria Venture Sign Agreement to Develop Potential New Antimalarial Drug

  • 30/09/2016
  • |
  • bse

Cadila Healthcare Ltd Zydus and Takeda enter into partnership to address emerging infectious diseases

  • 20/09/2016
  • |
  • bse

Cadila Healthcare Ltd Updates

  • 02/09/2016
  • |
  • bse

Cadila Healthcare Ltd Updates

  • 16/08/2016
  • |
  • bse

Cadila Healthcare Ltd Zydus strengthens its derma portfolio with the brand acquisition of MELGAIN from Issar Pharma in Ind

  • 08/08/2016
  • |
  • bse

Cadila Healthcare Ltd Updates

  • 05/08/2016
  • |
  • bse

Cadila Healthcare Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)

  • 05/08/2016
  • |
  • bse

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard